Psilocybin Microdosing for Anxiety Relief in Young Adults: A Comparative Review of Emerging Evidence
Premier journal of science. December 3, 2024 DOI: 10.70389/pjs.100036 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Systematic review Peer reviewed |
|---|---|
| Population | Young adults aged 18-35 years |
| Intervention | Psilocybin microdosing |
| Topics | Anxiety Psilocybin Microdosing |
| Keywords | Clinical psychology Hallucinogen |
| Key findings | Psilocybin microdosing is associated with improved mood, reduced anxiety symptoms, and enhanced emotional resilience and mental well-being in young adults. |
Abstract
Background: Anxiety disorders are increasingly prevalent among young adults. Traditional treatment options often fall short, and many patients live with treatment-resistant anxiety. Psilocybin is a psychedelic compound that has gained attention for its therapeutic potential against anxiety when used in microdoses.
Objective: This review aims to evaluate the emerging evidence on psilocybin microdosing as a potential intervention for anxiety relief in young adults. It examines psilocybin microdosing efficacy, safety, and underlying mechanism of action.
Methods: A systematic search was conducted across three major databases: PubMed, PsycINFO, and CINAH. Keywords were selected related to psilocybin microdosing and anxiety in young adults. Inclusion criteria focused on peer-reviewed studies published in English from 2014 to 2024, encompassing human participants aged 18-35 years. Data were synthesised narratively with thematic analysis of anxiety-related outcomes across studies. Tabular comparisons to highlight psilocybin microdosing’s relative efficacy, limitations, and methodological variations were used.
Findings: The findings suggest that psilocybin microdosing is associated with improved mood and reduced anxiety symptoms. It also enhances emotional resilience and mental well-being. Microdosing can modulate serotonin receptors, promote neural plasticity, and improve connectivity in certain brain regions implicated in emotional regulation. Short-term benefits include increased focus and cognitive flexibility, while long-term effects may involve sustained reductions in anxiety and improved overall mental well-being.
Conclusion: Psilocybin microdosing presents a promising alternative for managing anxiety in young adults for those who are resistant to traditional therapies. However, the variability in study designs and dosing regimens highlights the need for further research to establish standardised protocols and assess long-term safety and efficacy.